Evidence map›Paper›PMID 22260946›Full record

Trial reportCirculation. Heart failure2012

Should women receive left ventricular assist device support?: findings from INTERMACS.

Eileen M Hsich, David C Naftel, Susan L Myers, Eiran Z Gorodeski, Kathleen L Grady, Darlene Schmuhl, Karen L Ulisney, James B Young

Open access · bronzeAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Circulation. Heart failure, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Cardiomyopathies in Women.Methodist DeBakey cardiovascular journal · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Sex disparities in the current era of pediatric heart transplantation in the United States.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Gender Differences in Mortality After Left Ventricular Assist Device Implant: A Causal Mediation Analysis Approach.ASAIO journal (American Society for Artificial Internal Organs : 1992) · 2021
    Article
  15. Article
  16. Sex and Heart Failure Treatment Prescription and Adherence.Frontiers in cardiovascular medicine · 2021
    Review
  17. Article
  18. Sex Influence on Heart Failure Prognosis.Frontiers in cardiovascular medicine · 2020
    Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Eileen M HsichCollege of Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. hsiche@ccf.org
David C Naftel
Susan L Myers
Eiran Z Gorodeski
Kathleen L Grady
Darlene Schmuhl
Karen L Ulisney
James B Young
University of Alabama at Birmingham · USNorthwestern University · US

Funding

NHLBI NIH HHS HHSN268201100025C
6 · The paper itself

Abstract

backgroundSmall studies have reported women to have worse outcomes and more adverse events after implantation of mechanical circulatory support device compared with men. To further evaluate sex differences in outcome, we used the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). METHODS AND

resultsThere were 401 women (pulsatile devices=78) and 1535 men (pulsatile devices=402) from 89 institutions who were prospectively enrolled into the INTERMACS database for primary implantation of a left ventricular assist device (LVAD) between June 23, 2006, and March 31, 2010. Extensive preimplantation and outcome data were collected on all patients. With a mean follow-up of 7 months, 67 females (17%) died and 250 males (16%) died. There was no statistically significant sex difference in mortality for either pulsatile-flow (P=0.82) or continuous-flow (P=0.95) devices in adjusted and unadjusted models. There were also no statistically significant sex differences with time to first infection, bleeding, or device malfunction. However, female sex was associated with an increased hazard of first neurological event (adjusted hazard ratio, 1.44; 95% CI, 1.05-1.96; P=0.020).

conclusionsThere were no significant sex differences in mortality, time to first infection, bleeding, or device malfunction with either pulsatile- or continuous-flow LVADs. However, women had an increased risk of first neurological event. For urgent/emergent mechanical support, the benefit of LVAD support likely outweighs the risk, but it remains less clear for women undergoing elective LVAD implantation.

Indexed as

Decision MakingHeart-Assist DevicesVentricular Function, LeftAge DistributionFemaleFollow-Up StudiesHeart FailureHumansMaleMiddle AgedProspective StudiesRegistriesRisk FactorsSex DistributionSurvival RateTreatment Outcome

Identifiers

PMID22260946
PMCPMC4830091
OpenAlexW2161816609

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.